Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer. [electronic resource]
Producer: 20010222Description: 4665-72 p. digitalISSN:- 0250-7005
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Chemotherapy, Adjuvant
- Chi-Square Distribution
- Colonic Neoplasms -- drug therapy
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Infusions, Intravenous
- Injections, Intravenous
- Leucovorin -- administration & dosage
- Levamisole -- administration & dosage
- Male
- Middle Aged
- Neoplasm Staging
- Portal System
- Radiotherapy, Adjuvant
- Rectal Neoplasms -- drug therapy
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.